← Back to Analyst Consensus 
ACHC Buy
Acadia Healthcare Company, Inc.
Current Price —
Implied Upside —
Analysts 20
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 4, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | — | 51% |
| Jul 30, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 30, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Jul 20, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 14, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Jul 14, 2026 | Keybanc | maintain | Overweight → Overweight | — | 53% |
| Jul 9, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Jun 3, 2026 | Jefferies | upgrade | Hold → Buy | — | 52% |
| May 4, 2026 | RBC Capital | maintain | Outperform → Outperform | — | 55% |
| May 4, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| May 1, 2026 | Cantor Fitzgerald | maintain | Neutral → Neutral | — | 50% |
| May 1, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Apr 28, 2026 | TD Cowen | maintain | Buy → Buy | — | 54% |
| Apr 17, 2026 | UBS | maintain | Buy → Buy | — | 54% |
| Mar 3, 2026 | Barclays | maintain | Equal-Weight → Equal-Weight | — | 53% |
| Feb 26, 2026 | Leerink Partners | maintain | Market Perform → Market Perform | $22 | 51% |
| Feb 26, 2026 | UBS | maintain | Buy → Buy | $27 | 54% |
| Feb 26, 2026 | TD Cowen | maintain | Buy → Buy | $24 | 54% |
| Feb 26, 2026 | RBC Capital | maintain | Outperform → Outperform | $28 | 55% |
| Feb 23, 2026 | Guggenheim | maintain | Buy → Buy | $22 | 52% |
| Jan 22, 2026 | Jefferies | downgrade | Buy → Hold | $15 | 52% |
| Jan 16, 2026 | TD Cowen | maintain | Buy → Buy | $22 | 54% |
| Jan 14, 2026 | RBC Capital | maintain | Outperform → Outperform | $17 | 55% |
| Dec 18, 2025 | Mizuho | maintain | Neutral → Neutral | $17 | 52% |
| Dec 4, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $14 | 53% |
| Dec 3, 2025 | RBC Capital | maintain | Outperform → Outperform | $19 | 55% |
| Dec 3, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $17 | 50% |
| Dec 3, 2025 | Keybanc | maintain | Overweight → Overweight | $25 | 53% |
| Dec 3, 2025 | UBS | maintain | Buy → Buy | $24 | 54% |
| Dec 3, 2025 | Deutsche Bank | maintain | Buy → Buy | $20 | 57% |
| Dec 3, 2025 | B of A Securities | downgrade | Neutral → Underperform | $13 | 53% |
| Dec 3, 2025 | Leerink Partners | downgrade | Outperform → Market Perform | $14 | 51% |
| Nov 18, 2025 | Keybanc | maintain | Overweight → Overweight | $30 | 53% |
| Nov 12, 2025 | RBC Capital | maintain | Outperform → Outperform | $22 | 55% |
| Nov 10, 2025 | Guggenheim | maintain | Buy → Buy | $27 | 52% |
| Nov 7, 2025 | UBS | maintain | Buy → Buy | $28 | 54% |
| Nov 7, 2025 | Cantor Fitzgerald | maintain | Neutral → Neutral | $22 | 50% |
| Nov 6, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $17 | 53% |
| Oct 8, 2025 | Keybanc | maintain | Overweight → Overweight | $35 | 53% |
| Oct 7, 2025 | Cantor Fitzgerald | reiterate | Neutral → Neutral | $25 | 50% |
| Oct 3, 2025 | Raymond James | maintain | Outperform → Outperform | $30 | 54% |
| Sep 10, 2025 | B of A Securities | downgrade | Buy → Neutral | $25 | 53% |
| Aug 14, 2025 | Raymond James | downgrade | Strong Buy → Outperform | $26 | 54% |
| Aug 14, 2025 | Mizuho | maintain | Neutral → Neutral | $22 | 52% |
| Aug 13, 2025 | RBC Capital | maintain | Outperform → Outperform | $28 | 55% |
| Aug 7, 2025 | TD Cowen | maintain | Buy → Buy | $25 | 54% |
| Aug 7, 2025 | UBS | maintain | Buy → Buy | $31 | 54% |
| Aug 7, 2025 | Guggenheim | maintain | Buy → Buy | $29 | 52% |
| Aug 7, 2025 | Barclays | maintain | Equal-Weight → Equal-Weight | $20 | 53% |
Price Target Trend
Apr 13, 2026 Oct 26, 2026
EPS Estimates
+1q —
0q —
+1y —
0y —
Cross-Platform Signals
No cross-platform signals in the last 90 days